title: Bromocriptine for diabetes mellitus type II.
abstract: A quick-release formulation of bromocriptine is the latest drug approved by the US Food and Drug Administration for the treatment of type 2 diabetes mellitus. Most interestingly, the development of this drug stems from studies of hibernation in rodents. This article will review the physiology that led to the development of this new drug, as well as its indications, clinical use, benefits, and contraindications.
authors: Department of Medicine, Division of Endocrinology, New York Medical College, Valhalla, NY, USA. Guy_Valiquette@nymc.edu
authors: Guy
authors: G
authors: Valiquette
mesh_terms: D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006605:Hibernation; D006801:Humans; D007333:Insulin Resistance
chemical_list: D001971:Bromocriptine